Abstract 4345167: A Contemporary Machine Learning-Based Risk Stratification for Mortality and Hospitalization in Heart Failure with Preserved Ejection Fraction Using Multimodal Real-World Data
Background: Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous condition with high morbidity and mortality. Risk stratification of patients with HFpEF is important for advancing therapeutic development and improving clinical care. Research Question: Predicting overall mortality and heart failure (HF) Hospitalization in real world HFpEF population Aims : to leverage machine learning model to develop prognostic models based on real-world data, with the potential to support risk stratification in routine clinical practice Methods: CONFIDENT is an observational, multi-cohort study across three centers in Europe and the US. Patients with HFpEF, according to the HFA-PEFF criteria with ≥ 2 years of follow-up, were included from 2013 to 2022. The dataset included multimodal data from electronic health records, lab tests, echocardiography, and electrocardiography, with 82 baseline candidate variables. We developed machine learning-based prognostic models to predict all-cause mortality and HF hospitalization. Model performance was compared to conventional risk score in an external validation cohort. Results: A total of 1208 patients were included in the study. The mean age was 72±12. The 2-year risk of HF hospitalization and all-cause mortality ranged from 13 to 44% and 9 to 19% respectively. The all-cause mortality prognostic model achieved good discrimination with a C-index of 0.67 [95%CI, 0.66-0.68], and 0.68 [95%CI 0.66-0.69] in the training cohorts, and 0.72 [95%CI 0.65-0.78] in the validation cohort, and performed better than the PREDICT-HFpEF score (C-index: 0.66 [95%CI 0.65-0.68], p-value =0.012; 0.60, [95%CI 0.59-0.62],p-value < 0.01 and 0.67 [95%CI 0.58-0.73], p-value =0.013 respectively. Similar results were observed when compared to the Meta-Analysis Global Group In Chronic Heart Failure Risk Score (MAGGIC). Similarly, the model derived for HF hospitalization outperformed PREDICT-HFpEF and MAGGIC + natriuretic peptide. Conclusion: CONFIDENT prognostic models for all-cause mortality and HF hospitalization using routinely collected variables can reliably predict outcomes and facilitate personalized care and trial recruitment strategies in HFpEF.
Authors
- Tobias Zehnder (ORCID: https://orcid.org/0000-0002-4127-2673)
- Suresh Balu (ORCID: https://orcid.org/0000-0003-4929-9130)
- Manesh R. Patel (ORCID: https://orcid.org/0000-0002-2393-0855)
- Iva Mayer
- Maxime Touzot (ORCID: https://orcid.org/0000-0002-0510-2431)
- Javed Butler (ORCID: https://orcid.org/0000-0001-7683-4720)
- Jerremy Weerts (ORCID: https://orcid.org/0000-0002-9369-3453)
- Félix Balazard (ORCID: https://orcid.org/0000-0003-3336-0128)
- Mohammad Hallal (ORCID: https://orcid.org/0000-0003-1624-9647)
- Aruna D. Pradhan (ORCID: https://orcid.org/0000-0003-4321-5960)
- Bradley J. Hintze (ORCID: https://orcid.org/0000-0002-4871-2096)
- Marzia Rigolli (ORCID: https://orcid.org/0000-0001-9769-6224)
- Vanessa P. M. van Empel (ORCID: https://orcid.org/0000-0002-6864-0296)
- Ciro Esposito (ORCID: https://orcid.org/0000-0002-7906-1097)
- Benoît Sauty
- Mariann Micsinai Balan
- Nicolas Loiseau (ORCID: https://orcid.org/0000-0003-3783-0879)
- Marat Fudim
- Francisco Torres (ORCID: https://orcid.org/0000-0002-0003-2446)
- Paul Kessler
- Lars Lund
Institutions
- Bristol-Myers Squibb (Germany) (DE)
- Duke University (US)
- Maastricht University Medical Centre (NL)
- Clinical Research Institute (US)
- Bristol-Myers Squibb (United States) (US)
- Karolinska Development (Sweden) (SE)
- Duke Medical Center (US)
- Bristol-Myers Squibb (Sweden) (SE)
Publication Details
- Journal
- Circulation
- Published
- 2025-11-03
- DOI
- https://doi.org/10.1161/circ.152.suppl_3.4345167
- Primary Topic
- Cardiovascular Health and Risk Factors
- Type
- article
- Field-Weighted Citation Impact
- 0.00